Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2018 1
2019 1
2020 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Melanoma Adjuvant Treatment: Current Insight and Clinical Features.
D'Aniello C, Perri F, Scarpati GDV, Pepa CD, Pisconti S, Montesarchio V, Wernert N, Zarone MR, Caraglia M, Facchini G, Berretta M, Cavaliere C. D'Aniello C, et al. Curr Cancer Drug Targets. 2018;18(5):442-456. doi: 10.2174/1568009617666170208163714. Curr Cancer Drug Targets. 2018. PMID: 28183255 Review.
Adjuvant systemic treatment for high-risk resected non-cutaneous melanomas: What is the evidence?
Tapia Rico G, Yong CH, Herrera Gómez RG. Tapia Rico G, et al. Crit Rev Oncol Hematol. 2021 Nov;167:103503. doi: 10.1016/j.critrevonc.2021.103503. Epub 2021 Oct 14. Crit Rev Oncol Hematol. 2021. PMID: 34656746 Review.
Non-cutaneous melanomas demonstrate differences in tumour biology, generally present with more advanced stages and have an overall poorer prognosis compared to skin melanomas. The cornerstone of their treatment is surgery followed by radiotherapy in some cases. ...
Non-cutaneous melanomas demonstrate differences in tumour biology, generally present with more advanced stages and have an overall poorer …
Clinical features and response to systemic therapy in NRAS-mutant Chinese melanoma patients.
Wang J, Jiang H, Huang F, Li D, Wen X, Ding Q, Ding Y, Zhang X, Li J. Wang J, et al. J Cancer Res Clin Oncol. 2023 Feb;149(2):701-708. doi: 10.1007/s00432-022-04377-4. Epub 2022 Dec 1. J Cancer Res Clin Oncol. 2023. PMID: 36454283
PURPOSE: The prognosis of patients with NRAS-mutant melanoma is rather poor. Immunotherapy and targeted therapy have revolutionized anti-tumor therapy, especially for melanoma. ...
PURPOSE: The prognosis of patients with NRAS-mutant melanoma is rather poor. Immunotherapy and targeted therapy have revolutionized a …
Vulvar Melanoma in association with germline MITF p.E318K variant.
Koeller DR, Schwartz A, DeSimone MS, Rana HQ, Rojas-Rudilla V, Russell-Goldman E, Laga AC, Lindeman NI, Garber JE, Ghazani AA. Koeller DR, et al. Cancer Genet. 2022 Apr;262-263:102-106. doi: 10.1016/j.cancergen.2022.02.003. Epub 2022 Feb 15. Cancer Genet. 2022. PMID: 35220194
Vulvar melanoma is a rare and aggressive cancer with a poor prognosis. The etiology of mucosal melanoma remains largely uncharacterized and no hereditary risk factors are established for this rare disease. ...
Vulvar melanoma is a rare and aggressive cancer with a poor prognosis. The etiology of mucosal melanoma remains largely uncharacteriz …
Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis.
Delgado-Ramos GM, Thomas F, VanderWalde A, King B, Wilson M, Pallera AM. Delgado-Ramos GM, et al. Med Oncol. 2019 Jan 21;36(2):17. doi: 10.1007/s12032-018-1230-4. Med Oncol. 2019. PMID: 30666496
We describe the characteristics of UM patients at a tertiary referral center in the Mid-Southern United States, and explore associations and predictors of outcomes. This is a retrospective cohort study of patients with UM seen at West Cancer Center, from 07/2006 to 08/2017 …
We describe the characteristics of UM patients at a tertiary referral center in the Mid-Southern United States, and explore associations and …
Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study.
Kim HS, Kim EK, Jun HJ, Oh SY, Park KW, Lim DH, Lee SI, Kim JH, Kim KM, Lee DH, Lee J. Kim HS, et al. BMC Cancer. 2010 Apr 28;10:167. doi: 10.1186/1471-2407-10-167. BMC Cancer. 2010. PMID: 20426858 Free PMC article.
BACKGROUND: We performed multicenter study to define clinical characteristics of noncutaneous melanomas and to establish prognostic factors patients who received curative resection. METHODS: Of the 141 patients who were diagnosed of non-cutaneous melanoma at 4 institutions …
BACKGROUND: We performed multicenter study to define clinical characteristics of noncutaneous melanomas and to establish prognostic f …